SOPHiA GENETICS, a leading cloud-native healthcare technology company, has announced a significant partnership with Jessa Ziekenhuis in Hasselt, Belgium. The collaboration aims to provide advanced genomic testing and oncological research for cancer patients across Belgium. By leveraging SOPHiA GENETICS' automated, cloud-native solutions tailored for oncology, Jessa Ziekenhuis will be able to streamline workflows, accelerate insights, and enhance patient care throughout the country. This partnership marks an expansion of SOPHiA GENETICS' presence in European hospital networks, furthering the advancement of data-driven precision medicine.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sophia Genetics SA published the original content used to generate this news brief via PR Newswire (Ref. ID: GE65965) on September 08, 2025, and is solely responsible for the information contained therein.